Consumer Medicine Information (CMI) about Sacubitril/Valsartan Alphapharm intended for persons living in Australia.

Novartis is on course for a sales leap for Entresto, after FDA advisors back new heart failure claim by 12 votes to 1 ...

In a single phase III study, coadministration of sacubitril/valsartan with atorvastatin resulted in an increased Cmax of atorvastatin and its metabolites by up to 2-fold and AUC by up to 1.3-fold; ...

This study aims to investigate the feasibility and effects of sacubitril/valsartan treatment in a single-centre cohort of patients. Methods Data on all consecutive adult patients (n=20, mean age 46 ...

Background —We investigated the effects of candesartan (an angiotensin II antagonist) alone, enalapril alone, and their combination on exercise tolerance, ventricular function, quality of life (QOL), ...

Valsartan Valsartan (Diovan, Novartis) was the second nonpeptide AT-II type 1- receptor antagonist available for the treatment of hypertension. Valsartan is rapidly absorbed from the ...